News Archives - Page 584 of 703

ThursdayMay 30, 2019 10:01 am

INmune Bio Inc. (NASDAQ: INMB) Developing Novel Immunotherapies Targeting Alzheimer’s Disease, Cancer

INmune Bio is a diversified, clinical stage immunology company developing novel therapies targeting distinct parts of a patient’s innate immune system to fight disease Drug candidates INKmune and INB03 may be used to treat cancer; XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease The company was awarded a $1 million “Part the Cloud” grant from the Alzheimer’s Association to advance XPro1595 research INmune recently entered a common stock purchase agreement for up to $20 million with Lincoln Park Capital INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to…

WednesdayMay 29, 2019 11:30 am

South Africa Distribution Pact Expands Global Reach of Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The global hemp cannabidiol market is expected to top $22 billion worldwide by 2022, with CBD products comprising 25 percent of all cannabis sales Wildflower Brands is expanding the wellness reach of its cannabis products through a distribution pact with South African cannabis network provider Africann The company is also launching into Europe with a Polish network agreement through pharmaceutical distributor Two Towers Cannabis-based wellness brand champion Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues to expand the reach of its holistic plant product portfolio, inking an exclusive distribution agreement for the South African natural betterment market this month. The…

WednesdayMay 29, 2019 11:07 am

Genprex Inc. (NASDAQ: GNPX) Hires Top Pharmaceutical Branding Agency to Oversee Drug Naming Process for Lead Drug Candidate

Genprex, a clinical stage gene therapy company, will be utilizing the services of a leading pharmaceutical branding agency to oversee the naming process of its lead drug candidate, Oncoprex Addison Whitney has over 28 years of experience in the market, guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps involved in the name approval process Oncoprex is an innovative immunogene therapy targeting non-small cell lung cancer Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, recently reported that it has retained the services of leading pharmaceutical branding agency Addison Whitney to assist with the naming…

WednesdayMay 29, 2019 10:44 am

Beyond Meat Inc. (NASDAQ: BYND) to Release Financial Results for Q1 2019 in June

Beyond Meat’s financial results will be announced during a conference call scheduled for June 6 A live webcast will also be available via the company’s official website for investors interested in the financial information Beyond Meat’s portfolio of plant-based foods that replicate the taste and texture of meat has grown in popularity since the company’s launch in 2009, and its products are now available at more than 30,000 retail locations around the world Beyond Meat Inc. (NASDAQ: BYND), a leading provider of plant-based meat substitute products, recently announced that its financial results for the first quarter of 2019 will be…

WednesdayMay 29, 2019 10:09 am

INmune Bio Inc. (NASDAQ: INMB) is “One to Watch”

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation as a cause of Alzheimer’s disease Receiver of “Part the Cloud” $1 million grant awarded by Alzheimer’s Association Experienced leadership with extensive experience in the targeted fields of clinical research and drug development Intellectual property with multiple filings in process for INB03/XPro1595 and INKmune Insider…

TuesdayMay 28, 2019 12:31 pm

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Seeks to Transform Cannabis Beverage and Edibles Market with Water-Soluble Tech

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids The Canadian cannabis beverage market is estimated to exceed $4 billion by 2022 SRUTF executives were tapped to present APP technology at key cannabis conferences Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) is rapidly gaining positive exposure in the cannabis space as the company presents its proprietary APP technological platform at numerous key cannabis conferences in the U.S. and Canada. Sproutly executives most recently shared details of the APP process at the Canaccord Genuity Third Annual Cannabis Conference…

TuesdayMay 28, 2019 12:09 pm

Genprex Inc. (NASDAQ: GNPX) Pioneering an Innovative Cancer Therapy, Preclinical Data Shows Positive Results

Gene therapy could help overcome barriers that currently stand in the way of a cure for cancer Genprex is developing innovative, gene-based approaches toward the treatment of cancer, specifically non-small cell lung cancer Clinical trials so far have yielded encouraging data regarding the efficacy and safety of the company’s product candidate, Oncoprex Gene therapy could potentially advance the creation and delivery of effective cancer treatments in the years to come. Various companies are leading the way, and pioneers such as Genprex Inc. (NASDAQ: GNPX) are pushing for the introduction of innovative and targeted therapies that have the potential to help…

TuesdayMay 28, 2019 11:47 am

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Closes Financing, Proceeds Earmarked for Extraction Technology

Petroteq Energy completed a private placement of almost $1 million, generating funds that will be used to continue development of its proprietary technology for the environmentally-safe extraction of heavy oil Currently utilized at the Petroteq extraction facility in the Utah Asphalt Ridge pilot project, the technology could revolutionize the oil industry The company has already reported consistent production at the facility, with plans to expand capacity over the next 24 months Oil and gas industry technology innovator Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) recently announced the closing of a private placement generating aggregate gross proceeds of $985,950 for a…

TuesdayMay 28, 2019 11:21 am

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Developing Offerings for Sophisticated Cannabis Consumers

Plus Products creates cannabis edibles to support healthier lifestyles The company offers top products in the adult-use, medical and CBD segments PLUS recently reported record revenues for Q4 2018 Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) is a foremost cannabis-branded products manufacturer with a mission to make cannabis safe and approachable. Based in San Mateo, California, Plus Products manufactures edibles created to support a healthy and active lifestyle. The company focuses on producing edibles using extracts to ensure compliant, dosable and appetizing options that provide a consistent cannabis experience. All of its products are manufactured in its 12,000-square-foot, food-safe cannabis…

Site Search

Company Search

Category: News